These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 27392503)

  • 1. Systemic-onset juvenile idiopathic arthritis.
    Cimaz R
    Autoimmun Rev; 2016 Sep; 15(9):931-4. PubMed ID: 27392503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications of systemic juvenile idiopathic arthritis: risk factors and management recommendations.
    Woerner A; von Scheven-Gête A; Cimaz R; Hofer M
    Expert Rev Clin Immunol; 2015 May; 11(5):575-88. PubMed ID: 25843554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic Juvenile Idiopathic Arthritis: Diagnosis and Management.
    Kumar S
    Indian J Pediatr; 2016 Apr; 83(4):322-7. PubMed ID: 26916892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic-onset juvenile idiopathic arthritis: the changing life of a rare disease.
    Cimaz R; Von Scheven A; Hofer M
    Swiss Med Wkly; 2012; 142():w13582. PubMed ID: 22573189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: clinical experience from northwest India.
    Singh S; Chandrakasan S; Ahluwalia J; Suri D; Rawat A; Ahmed N; Das R; Sachdeva MU; Varma N
    Rheumatol Int; 2012 Apr; 32(4):881-6. PubMed ID: 21221591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic Juvenile Idiopathic Arthritis.
    Lee JJY; Schneider R
    Pediatr Clin North Am; 2018 Aug; 65(4):691-709. PubMed ID: 30031494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage activation syndrome in an inadequately treated patient with systemic onset juvenile idiopathic arthritis.
    Juneja M; Jain R; Mishra D
    Kathmandu Univ Med J (KUMJ); 2009; 7(28):411-3. PubMed ID: 20502084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic juvenile idiopathic arthritis: New insights into pathogenesis and cytokine directed therapies.
    Pardeo M; Bracaglia C; De Benedetti F
    Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):505-516. PubMed ID: 29773270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the pathogenesis and treatment of systemic juvenile idiopathic arthritis.
    Correll CK; Binstadt BA
    Pediatr Res; 2014 Jan; 75(1-2):176-83. PubMed ID: 24213625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: analysis of 13 patients].
    Shi H; Wang HW; Cheng PX; Hu XF; Liu QJ; Wan LJ
    Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):812-7. PubMed ID: 17274866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage activation syndrome in 13 children with systemic-onset juvenile idiopathic arthritis.
    Zeng HS; Xiong XY; Wei YD; Wang HW; Luo XP
    World J Pediatr; 2008 May; 4(2):97-101. PubMed ID: 18661762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic Juvenile Idiopathic Arthritis Complicated by Macrophage Activation Syndrome.
    Wagner-Weiner L
    Pediatr Ann; 2015 Jun; 44(6):e142-7. PubMed ID: 26114369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained hyperferritinemia in a child with macrophage activation syndrome secondary to systemic juvenile idiopathic arthritis - perforinopathy: case based review.
    Çakan M; Aktay-Ayaz N; Gemici H; Annayev A; Çıtak A; Akçay A; Öztürk G
    Turk J Pediatr; 2018; 60(5):598-603. PubMed ID: 30968645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural Killer Cells in Systemic Autoinflammatory Diseases: A Focus on Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.
    Vandenhaute J; Wouters CH; Matthys P
    Front Immunol; 2019; 10():3089. PubMed ID: 32010140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble CD25 in serum: a potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis.
    Reddy VV; Myles A; Cheekatla SS; Singh S; Aggarwal A
    Int J Rheum Dis; 2014 Mar; 17(3):261-7. PubMed ID: 24417800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
    Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
    Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of systemic inflammatory diseases in childhood: "Lessons from clinical trials of anti-cytokine monoclonal antibodies for Kawasaki disease, systemic onset juvenile idiopathic arthritis, and cryopyrin-associated periodic fever syndrome".
    Yokota S; Kikuchi M; Nozawa T; Kanetaka T; Sato T; Yamazaki K; Sakurai N; Hara R; Mori M
    Mod Rheumatol; 2015 Jan; 25(1):1-10. PubMed ID: 24842480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic JIA: new developments in the understanding of the pathophysiology and therapy.
    Vastert SJ; Kuis W; Grom AA
    Best Pract Res Clin Rheumatol; 2009 Oct; 23(5):655-64. PubMed ID: 19853830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis and Treatment of Refractory Disease Courses in Systemic Juvenile Idiopathic Arthritis: Refractory Arthritis, Recurrent Macrophage Activation Syndrome and Chronic Lung Disease.
    Erkens R; Esteban Y; Towe C; Schulert G; Vastert S
    Rheum Dis Clin North Am; 2021 Nov; 47(4):585-606. PubMed ID: 34635293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
    Shimizu M; Nakagishi Y; Inoue N; Mizuta M; Ko G; Saikawa Y; Kubota T; Yamasaki Y; Takei S; Yachie A
    Clin Immunol; 2015 Oct; 160(2):277-81. PubMed ID: 26101092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.